|
Volumn 20, Issue 2, 2015, Pages 59-
|
Evidence is weak to support hepatocellular carcinoma screening in chronic liver disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA FETOPROTEIN;
CANCER MORTALITY;
CANCER SCREENING;
CHRONIC LIVER DISEASE;
CLINICAL TRIAL (TOPIC);
ECHOGRAPHY;
EVIDENCE BASED PRACTICE;
HUMAN;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
NOTE;
OBSERVATIONAL STUDY;
PROTEIN ANALYSIS;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SENSITIVITY AND SPECIFICITY;
SYSTEMATIC REVIEW (TOPIC);
CARCINOMA, HEPATOCELLULAR;
COMPLICATION;
EARLY DIAGNOSIS;
LIVER DISEASE;
LIVER NEOPLASMS;
MASS SCREENING;
MORTALITY;
CARCINOMA, HEPATOCELLULAR;
EARLY DETECTION OF CANCER;
HUMANS;
LIVER DISEASES;
LIVER NEOPLASMS;
MASS SCREENING;
|
EID: 84928124921
PISSN: 13565524
EISSN: 14736810
Source Type: Journal
DOI: 10.1136/ebmed-2014-110107 Document Type: Note |
Times cited : (1)
|
References (8)
|